Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:992-999
Published online before print August 21, 2006, doi: 10.1161/CIRCULATIONAHA.106.617613
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
114/10/992    most recent
CIRCULATIONAHA.106.617613v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bucchi, A.
Right arrow Articles by Rosen, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bucchi, A.
Right arrow Articles by Rosen, M. R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Medline Plus Health Information
*Pacemakers and Implantable Defibrillators
Related Collections
Right arrow Electrophysiology
Right arrow Pacemaker
Right arrow Animal models of human disease
Right arrow Arrythmias-basic studies
Right arrow Electrocardiology
Right arrow Gene therapy

(Circulation. 2006;114:992-999.)
© 2006 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Wild-Type and Mutant HCN Channels in a Tandem Biological-Electronic Cardiac Pacemaker

Annalisa Bucchi, PhD*; Alexei N. Plotnikov, MD*; Iryna Shlapakova, MD*; Peter Danilo, Jr, PhD; Yelena Kryukova, PhD; Jihong Qu, PhD; Zhongju Lu, MD, PhD; Huilin Liu, MD; Zongming Pan, PhD; Irina Potapova, PhD; Bruce Ken Knight, PhD; Steven Girouard, PhD; Ira S. Cohen, MD, PhD; Peter R. Brink, PhD; Richard B. Robinson, PhD; Michael R. Rosen, MD

From the Departments of Pharmacology (A.B., A.N.P., I.S., P.D., Y.K., I.S.C., R.B.R., M.R.R.) and Pediatrics (M.R.R.), Center for Molecular Therapeutics, Columbia University, New York, NY; Guidant Corporation, St Paul, Minn (J.Q., B.K., S.G.); and Departments of Physiology and Biophysics, Institute of Molecular Cardiology, State University of New York at Stony Brook (Z.L., H.L., Z.P., I.P., I.S.C., P.R.B., M.R.R.).

Correspondence to Michael R. Rosen, MD, Center for Molecular Therapeutics, College of Physicians and Surgeons of Columbia University, 630 W 168 St, PH7West-321, New York, NY 10032. E-mail mrr1{at}columbia.edu

Received February 6, 2006; revision received June 5, 2006; accepted June 9, 2006.

Background— Biological pacemakers (BPM) implanted in canine left bundle branch function competitively with electronic pacemakers (EPM). We hypothesized that BPM engineered with the use of mE324A mutant murine HCN2 (mHCN2) genes would improve function over mHCN2 and that BPM/EPM tandems confer advantage over either approach alone.

Methods and Results— In cultured neonatal rat myocytes, activation midpoint was –46.9 mV in mE324A versus –66.1 mV in mHCN2 (P<0.05). mE324A manifested a positive shift of voltage dependence of gating kinetics of activation and deactivation compared with mHCN2 (P<0.05) in myocytes as well as Xenopus oocytes. In intact dogs in complete atrioventricular block, saline (control), mHCN2, or mE324A virus was injected into left bundle branch, and EPM were implanted (VVI 45 bpm). Twenty-four–hour ECGs were monitored for 14 days. With EPM discontinued, there was no difference in duration of overdrive suppression among groups. However, basal heart rates in controls were less than those in mHCN2, which did not differ from those in E324A (45 versus 57 versus 53 bpm; P<0.05). When spontaneous rate fell below 45 bpm, EPM intervened at that rate, triggering 83% of beats in control, contrasting (P<0.05) with 26% (mHCN2) and 36% (mE324A). On day 14, epinephrine (1 µg/kg per minute IV) induced a 50% heart rate increase in all mE324A, one third of mHCN2, and one fifth of control (P<0.05 mE324A versus control or mHCN2).

Conclusions— mE324A induces faster, more positive pacemaker current activation than mHCN2 and stable, catecholamine-sensitive rhythms in situ that compete with EPM comparably but more catecholamine responsively than mHCN2. BPM/EPM tandems function reliably, reduce the number of EPM beats, and confer sympathetic responsiveness to the tandem.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Ther Adv Cardiovasc DisHome page
G. M. Morris and M. R. Boyett
Perspectives -- biological pacing, a clinical reality?
Therapeutic Advances in Cardiovascular Disease, December 1, 2009; 3(6): 479 - 483.
[Abstract] [PDF]


Home page
J. Physiol.Home page
V. Valiunas, G. Kanaporis, L. Valiuniene, C. Gordon, H. Z. Wang, L. Li, R. B. Robinson, M. R. Rosen, I. S. Cohen, and P. R. Brink
Coupling an HCN2-expressing cell to a myocyte creates a two-cell pacing unit
J. Physiol., November 1, 2009; 587(21): 5211 - 5226.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. Accili
Putting the pacemaker channel through its paces to build a better biological pacemaker
J. Physiol., April 1, 2009; 587(7): 1381 - 1382.
[Full Text] [PDF]


Home page
J. Physiol.Home page
X. Zhao, A. Bucchi, R. V. Oren, Y. Kryukova, W. Dun, C. E. Clancy, and R. B. Robinson
In vitro characterization of HCN channel kinetics and frequency dependence in myocytes predicts biological pacemaker functionality
J. Physiol., April 1, 2009; 587(7): 1513 - 1525.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. E. Mangoni and J. Nargeot
Genesis and Regulation of the Heart Automaticity
Physiol Rev, July 1, 2008; 88(3): 919 - 982.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
M. R. Rosen, P. R. Brink, I. S. Cohen, and R. B. Robinson
Cardiac Pacing: From Biological to Electronic ... to Biological?
Circ Arrhythm Electrophysiol, April 1, 2008; 1(1): 54 - 61.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. N. Plotnikov, I. Shlapakova, M. J. Szabolcs, P. Danilo Jr, B. H. Lorell, I. A. Potapova, Z. Lu, A. B. Rosen, R. T. Mathias, P. R. Brink, et al.
Xenografted Adult Human Mesenchymal Stem Cells Provide a Platform for Sustained Biological Pacemaker Function in Canine Heart
Circulation, August 14, 2007; 116(7): 706 - 713.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
W. M.H. Hoogaars, A. Engel, J. F. Brons, A. O. Verkerk, F. J. de Lange, L.Y. E. Wong, M. L. Bakker, D. E. Clout, V. Wakker, P. Barnett, et al.
Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria
Genes & Dev., May 1, 2007; 21(9): 1098 - 1112.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. B. Cowan and F. X. McGowan Jr
A Paradigm Shift in Cardiac Pacing Therapy?
Circulation, September 5, 2006; 114(10): 986 - 988.
[Full Text] [PDF]